Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Less than 40% of Public Aware that Antibacterials Are Ineffective Against Common Cold: Govt Survey
October 15, 2019
- Self-Medication Tax Break Not a Clear-Cut System, Needs More Awareness: LDP Lawmakers
October 11, 2019
- Chuikyo Wary about Further Reduction in Generic Entry Prices
October 10, 2019
- Japan Doctor, Pharmacist Groups Oppose Delisting of OTC-Like Drugs: LDP Taskforce
October 10, 2019
- Chuikyo Positive to Add Sakigake Drugs for PMP Coverage, Nudges Industry to Show Counterproposal for Company Criteria
October 10, 2019
- CEFP Discussions on Reform Timeline Update Get Underway
October 10, 2019
- As HIF-PH Inhibitor Debut Looms, MHLW Eyes New Medical Fee Schedule for Renal Anemia
October 10, 2019
- MHLW Kicks Off Discussions to Spur Genomic Medicine for Intractable Diseases
October 9, 2019
- Health Minister Keen on Passage of PMD Law Amendment in Extra Diet Session
October 8, 2019
- As Curtain Rises on Diet, MHLW Aims to Get Amended PMD Bill Enacted in Early November
October 7, 2019
- PMDA Reviewing Safety Risks for Takecab Products and More
October 7, 2019
- MOF Panel Kicks Off FY2020 Budget Debate, Prods Discussions on “Benefits and Burdens”
October 4, 2019
- MHLW Sets Up New Office to Take Reports on Inappropriate Detailing Activities from Healthcare Providers
October 3, 2019
- New Detailing Guidelines Go into Full Effect on October 1, Making Supervisory Systems Mandatory
October 1, 2019
- MHLW Panel Members Call for Discussion on Range of Health Coverage
September 30, 2019
- Rotavirus Vaccines Added to Public Vaccination Programs from Oct. 1, 2020: MHLW Panel
September 30, 2019
- Chuikyo Supports Earlier Price Cuts for Certain Off-Patent Brand-Name Drugs
September 26, 2019
- MHLW Orders Label Revisions for Actemra, Tagrisso, Olumiant and More
September 25, 2019
- Intussusception Cases within 21 Days after Rotavirus Vaccination Should Be Reported: MHLW Panels
September 25, 2019
- Japan Launches Panel to Discuss “Social Security for All Generations”
September 24, 2019
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…